🔎 Trials Near Me

Beranda › Kanker Paru Non-Sel Kecil › Louisiana › New Orleans

Uji klinis Kanker Paru Non-Sel Kecil di New Orleans, LA

9 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar New Orleans (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Menerima pesertaFase 3
  • University Medical Center New Orleans, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Ochsner Clinic Foundation, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06890598

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • Tulane Cancer Center, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

Menerima pesertaFase 1
  • LSU Health Sciences Center School of Medicine, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07361562

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Menerima pesertaFase 1/2
  • Local Institution - 2116, New Orleans
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Menerima pesertaFase 3
  • Tulane Cancer Center, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT07154706

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, New Orleans
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Menerima pesertaFase 1/2
  • Ochsner/MD Anderson Cancer Center, New Orleans
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT06228326

Uji klinis Kanker Paru Non-Sel Kecil di kota lain

Studi lain di New Orleans

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.